C4 Therapeutics, Inc.
Clinical-stage biotech company transforming how disease is treated through targeted protein degradation science
111 employees · est. 2015 · Watertown, United States
C4 Therapeutics, Inc. is the older company (2020 vs 2015); C4 Therapeutics, Inc. is the larger of the two.
1 signal in the last 90 days
Side-by-Side Comparison
| Metric | Amyl Therapeutics | C4 Therapeutics, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2020 | 2015 older |
| Headquarters | ||
| Headquarters | Liege, Belgium | Watertown, United States |
| Employees | ||
| Employees | 11 | 111 larger |
| Industry | ||
| Industry | Biotechnology, Health Care, Life Sciences | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Grant | IPO |
| Total Funding | ||
| Total Funding | $29.70M | $218.00M |
| Funding Rounds | ||
| Funding Rounds | 4 | 5 |
| Services | ||
| Services | Development of Pan-Amyloid Immunotherapy for amyloid-mediated diseases | Drug Discovery, Clinical Research, Partner Collaborations, Scientific Publications |
| Target Customers | ||
| Target Customers | Patients suffering from amyloid-mediated diseases, healthcare providers, pharmaceutical companies, research institutions | Patients and Families, Healthcare Providers, Investors, Pharmaceutical Companies |
| Taxonomy | ||
| Taxonomy | Therapeutics, Preclinical Research, Neurodegenerative Diseases, Protein Misfolding, Amyloid Diseases, Drug Development, Biochemistry, Medical Research, Neuroscience, Pharmaceuticals, Biopharmaceutical Research, Clinical Trials, Disease Treatment, Medical Innovation | Protein Degradation, Targeted Protein Degradation Science, Oncology Programs, TORPEDO® Platform, Small-Molecule Medicines, Drug Resistance Overcoming, Degronimids, Ubiquitin/Proteasome System, Biopharmaceuticals, Synthetic Chemical Compounds, Targeted Therapeutics, Cell Biology, Protein Chemistry, Cell Pharmacology, Dana-Farber Collaboration |
| Website | ||
| Website | amyltx.com | c4therapeutics.com |
About Amyl Therapeutics
Amyl Therapeutics is a preclinical-stage biotechnology company founded in 2020 and based in Belgium. The company's mission revolves around pioneering a breakthrough approach to treating severe peripheral amyloid protein misfolding diseases. With the slogan "Restoring clarity in amyloid diseases," Am...
About C4 Therapeutics, Inc.
C4 Therapeutics, Inc. is a clinical-stage biotech company that is revolutionizing the treatment of diseases through targeted protein degradation science. Founded in 2015 and headquartered in the United States, the company focuses on unleashing the potential of its proprietary TORPEDO® platform to de...
We will tell you when either one moves
BounceWatch watches Amyl Therapeutics and C4 Therapeutics, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Amyl Therapeutics and C4 Therapeutics, Inc. — by email.
Frequently Asked Questions
Compare Amyl Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Amyl Therapeutics on 13 Apr 2025, and C4 Therapeutics, Inc. on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
